News
Zacks Investment Research on MSN4h
PROK Surges More Than 500% on Upbeat Data From Kidney Cell Therapy StudyShares of ProKidney Corp. PROK skyrocketed 515% yesterday after the company reported encouraging top-line data from the phase ...
ProKidney shares surged 500% on positive Phase 2 CKD results. Read why I remain cautious about PROK stock despite the recent ...
THE Private Sector Advisory Council (PSAC) is pushing for accelerated government digitization and streamlined national ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback